Extracellular bad fused to toxin transport domains induces apoptosis

Cancer Research

Volumn 62, Issue 5, 2002, Pages 1433-1438

  Ichinose, Makoto ^a   Liu, Xiu Huai ^a   Hagihara, Naoshi ^a,b   Youle, Richard J ^a  

^a NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

^b SAGA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

DIPHTHERIA TOXIN; HYBRID PROTEIN; PROTEIN BAD; PROTEIN BCL XL;

ANIMAL CELL; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER CELL DESTRUCTION; CANCER INHIBITION; CELL STRAIN COS7; CONTROLLED STUDY; GENE FUSION; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN LOCALIZATION; RAT;

ANIMALS; APOPTOSIS; BCL-ASSOCIATED DEATH PROTEIN; BCL-X PROTEIN; BIOLOGICAL TRANSPORT; CARRIER PROTEINS; DIPHTHERIA TOXIN; HUMANS; PHOSPHORIC MONOESTER HYDROLASES; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-BCL-2; PTEN PHOSPHOHYDROLASE; RECOMBINANT FUSION PROTEINS; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEINS;

EID: 0036494705     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (51)

1. The Bcl-2 protein family: Arbiters of cell survival
2. Programmed cell death and the regulation of homeostasis
3. Bcl-2 heterodimerizes in vivo with a conserved homolog. Bax, that accelerates programmed cell death
4. Land Bcl-2, displaces Bax and promotes cell death
5. Cell survival promoted by the Ras-MAPK signaling pathway by transcription-dependent and -independent mechanisms
6. Phosphorylation and inactivation of BAD by mitochondria-anchored protein kinase A
7. Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery
8. Serine phosphorylation of death agonist BAD in response to survival factor results in binding to 14-3-3 not BCL-X
9. Growth factors inactivate the cell death promoter BAD by phosphorylation of its BH3 domain on SerI55
10. 14-3-3 Proteins and survival kinases cooperate to inactivate BAD by BH3 domain phosphorylation
11. Linteraction and cell survival
12. Regulation of BAD by cAMP-dependent protein kinase is mediated via phosphorylation of a novel site, Ser155
13. Phosphorylation of the pro-apoptotic protein BAD on serine 155, a novel site, contributes to cell survival
14. Entry of the toxic proteins abrin, modeccin, ricin, and diphtheria toxin into cells. II. Effect of pH, metabolic inhibitors, and ionophores and evidence for toxin penetration from endocytotic vesicles
15. Evidence for penetration of diphtheria toxin to the cytosol through a prelysosomal membrane
16. Processing of Pseudomonas exotoxin by a cellular protease results in the generation of a 37,000-Da toxin fragment that is translocated to the cytosol
17. Anthrax toxins
18. Peptides fused to the amino-terminal end of diphtheria toxin are translocated to the cytosol
19. Targeted delivery of peptide epitopes to class I major histocompatibility molecules by a modified Pseudomonas exotoxin
20. Anthrax toxin-mediated delivery in vivo and in vitro of a cytotoxic T-lymphocyte epitope from ovalbumin
21. Diphtheria toxin
22. Lfusion protein inhibits apoptosis
23. Inhibition of axotomy-induced neuronal apoptosis by extracellular delivery of a Bcl-XL fusion protein
24. A study of the intracellular routing of cytotoxic ribonucleases
25. Engineering receptor-mediated cytotoxicity into human ribonucleases by steric blockade of inhibitor interaction
26. Complete regression of established human glioblastome tumor xenografts by interlukin-4 toxin therapy
27. Diphtheria: Studies on the biology of an infectious disease
28. L
29. Lby the MAPK/Erk kinase
30. Delivery of antigens to the MHC class I pathway using bacterial toxins
31. Intracellular routing and membrane translocation of diphtheria toxin and ricin
32. Fused polycationic peptide mediates delivery of diphtheria toxin A chain to the cytosol in the presence of anthrax protective antigen
33. Interleukin 2-Bax: A novel prototype of human chimeric proteins for targeted therapy
34. BCL-2 family members and the mitochondria in apoptosis
35. Protein kinase B (c-Akt) in phosphatidylinositol-3-OH kinase signal transduction
36. Mechanisms and consequences of activation of protein kinase B/Akt
37. A surprising function for the PTEN tumor suppressor
38. PTEN: A tumor suppressor that functions as a phospholipid phosphatase
39. Akt is more than just a Bad kinase
40. PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer
41. Mutational profile of the PTEN gene in primary human astrocytic tumors and cultivated xenografts
42. Frequent inactivation of PTEN/MMAC1 in primary prostate cancer
43. Inactivation of the tumor suppressor PTEN/MMAC1 in advanced human prostate cancer through loss of expression
44. PTEN/MMAC1, is infrequently mutated in pT2 and pT3 carcinomas of the prostate
45. Interfocal heterogeneity of PTEN/MMAC1 gene alterations in multiple metastatic prostate cancer tissues
46. Adenoviral transgene expression of MMAC/PTEN in human glioma cells inhibits Akt activation and induces anoikis
47. Regulation of Akt/PKB activity, cellular growth, and apoptosis in prostate carcinoma cells by MMAC/PTEN
48. Growth suppression of glioma cells by PTEN requires a functional phosphatase catalytic domain
49. Inhibition of integrin-linked kinase (ILK) suppresses activation of protein kinase B/Akt and induces cell cycle arrest and apoptosis of PTEN-mutant prostate cancer cells
50. Mutations in diphtheria toxin separate binding from entry and amplify immunotoxin selectivity
51. Tumor regression with regional distribution of the targeted toxin TF-CRM107 in patients with malignant brain tumors